UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-10-31 | Future report Set alerts | |
| Q2 2022 | 2022-08-02 | -2.13 | -2.13 |
| Q1 2022 | 2022-05-03 | -2.07 | -2.07 |
| Q4 2021 | 2022-02-24 | -2.12 | -2.12 |
| Q3 2021 | 2021-11-02 | -2.21 | -2.21 |
| Q2 2021 | 2021-08-03 | -1.83 | -1.83 |
| Q1 2021 | 2021-05-04 | -1.64 | -1.64 |
| Q4 2020 | 2021-02-24 | 18.19 | 18.19 |
| Q3 2020 | 2020-11-05 | -2.03 | 0.00 |
| Q2 2020 | 2020-08-10 | -2.63 | -2.63 |
| 2016-07-12 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2016-07-12 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-07-12 | Reiterated Rating | Chardan Capital | Sell | |
| 2016-07-12 | Reiterated Rating | BMO Capital Markets | Buy | |
| 2016-07-12 | Reiterated Rating | Leerink Swann | Buy | $66.00 |
| 2016-06-28 | Initiated Coverage | BMO Capital Markets | Outperform | $48.00 |
| 2016-06-23 | Initiated Coverage | HC Wainwright | Buy | $56.00 |
| 2016-06-21 | Reiterated Rating | Leerink Swann | Outperform | $66.00 |
| 2016-06-08 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2016-06-08 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-06-08 | Reiterated Rating | Chardan Capital | Sell | |
| 2016-05-27 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2016-05-24 | Initiated Coverage | Chardan Capital | Sell | $18.00 |
| 2016-05-16 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-05-14 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2016-05-13 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-05-08 | Reiterated Rating | Canaccord Genuity | Buy | $110.00 |
| 2016-04-08 | Reiterated Rating | Leerink Swann | Buy | $66.00 |
| 2016-04-01 | Reiterated Rating | Goldman Sachs | Buy | $63.00 |
| 2016-04-01 | Reiterated Rating | Goldman Sachs Group Inc. | Buy | $63.00 |
| 2016-03-30 | Initiated Coverage | Goldman Sachs | Neutral | $83.00 |
| 2016-03-27 | Reiterated Rating | William Blair | Buy | |
| 2016-03-24 | Reiterated Rating | Canaccord Genuity | Buy | $110.00 |
| 2016-03-11 | Initiated Coverage | Lake Street Capital | Buy | $90.00 |
| 2016-02-26 | Lower Price Target | Leerink Swann | $66.00 | |
| 2016-02-25 | Lower Price Target | William Blair | Outperform | $58.00 |
| 2016-02-24 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2016-02-24 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2016-02-24 | Reiterated Rating | Cowen and Company | Buy | $108.00 to $95.00 |
| 2016-02-09 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2016-01-11 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | |
| 2015-12-15 | Reiterated Rating | Canaccord Genuity | Buy | $110.00 |
| 2015-11-07 | Reiterated Rating | Leerink Swann | Buy | |
| 2015-11-06 | Reiterated Rating | Leerink Swann | Outperform | $107.00 to $80.00 |
| 2015-10-21 | Reiterated Rating | William Blair | Outperform | $75.00 |
| 2015-10-06 | Reiterated Rating | Leerink Swann | Outperform | |
| 2015-09-04 | Reiterated Rating | William Blair | Buy | |
| 2015-09-03 | Reiterated Rating | Leerink Swann | Buy | |
| 2015-09-03 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | |
| 2015-08-13 | Reiterated Rating | Canaccord Genuity | Buy | $110.00 |
| 2015-08-07 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $71.00 |
| 2015-06-10 | Boost Price Target | Canaccord Genuity | Buy | $85.00 to $110.00 |
| 2015-06-09 | Set Price Target | Cowen and Company | Buy | $95.00 to $108.00 |
| 2015-06-09 | Set Price Target | Leerink Swann | Buy | $107.00 |
| 2015-06-09 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | |
| 2015-06-03 | Boost Price Target | Leerink Swann | Outperform | $70.00 to $93.00 |
| 2015-05-28 | Initiated Coverage | Cowen and Company | Outperform | $95.00 |
| 2015-05-21 | Boost Price Target | Canaccord Genuity | Buy | $58.00 to $85.00 |
| 2015-05-15 | Initiated Coverage | Goldman Sachs | Buy | $80.00 to $80.00 |
| 2015-05-14 | Reiterated Rating | JPMorgan Chase & Co. | Buy | $58.00 to $66.00 |
| 2015-05-14 | Reiterated Rating | Canaccord Genuity | Buy | $58.00 |
| 2015-05-14 | Set Price Target | Leerink Swann | Buy | $54.00 to $70.00 |
| 2015-04-06 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $51.00 to $58.00 |
| 2015-04-02 | Set Price Target | Canaccord Genuity | Buy | $58.00 |
| 2015-04-02 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2015-03-20 | Initiated Coverage | William Blair | Outperform | $75.00 |
| 2015-02-27 | Reiterated Rating | Canaccord Genuity | Buy | $58.00 |
| 2015-01-27 | Initiated Coverage | SunTrust | Buy | $67.00 |
| 2015-01-27 | Initiated Coverage | SunTrust Banks Inc. | Buy | $67.00 |
| 2015-01-13 | Reiterated Rating | Canaccord Genuity | Buy | $58.00 |
| 2015-01-09 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $51.00 |
| 2014-12-09 | Boost Price Target | Leerink Swann | Outperform | $46.00 to $54.00 |
| 2014-09-24 | Upgrade | Goldman Sachs | Neutral to Buy | $29.56 to $38.00 |
| 2014-08-12 | Initiated Coverage | Canaccord Genuity | Buy | $40.00 |
| 2014-08-12 | Initiated Coverage | JPMorgan Chase & Co. | Overweight | $42.00 |
| 2014-08-12 | Initiated Coverage | Goldman Sachs | Neutral | $38.00 |
| 2014-08-12 | Initiated Coverage | Leerink Swann | Outperform | $46.00 |
| 2016-07-12 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2016-07-12 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-07-12 | Reiterated Rating | Chardan Capital | Sell | |
| 2016-07-12 | Reiterated Rating | BMO Capital Markets | Buy | |
| 2016-07-12 | Reiterated Rating | Leerink Swann | Buy | $66.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In SAGE 165 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Third Rock Ventures, LLC | 6.44M |
| FMR LLC | 6.32M |
| WELLINGTON MANAGEMENT CO LLP | 4.93M |
| BlackRock Inc. | 4.82M |
| Vanguard Group, Inc | 4.79M |
| STATE STREET CORP | 2.95M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.14M |
| JPMORGAN CHASE & CO | 1.53M |
| OPPENHEIMER FUNDS INC | 1.44M |
| BlackRock Fund Advisors | 1.42M |
| GOLDMAN SACHS GROUP INC | 1.11M |
| Boxer Capital, LLC | 1.09M |
| AMERIPRISE FINANCIAL INC | 1.09M |
| DIMENSIONAL FUND ADVISORS LP | 1.08M |
| Marshall Wace LLP | 1.00M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Third Rock Ventures II, L.P. | 11.25% (2892916) | SAGE / |
| Arch Venture Fund VII LP | 8.26% (2124699) | AGIO / BLUE / JUNO / RCPT / RTGN / SAGE / |
| PAUL STEVEN M | 2.46% (632712) | ALNY / SAGE / SIAL / |
| STARR KEVIN P | 1.18% (302817) | AGIO / ALNY / SAGE / |
| Robichaud Albert Chief Scientific Officer | 0.59% (152759) | SAGE / |
| NELSEN ROBERT | 0.42% (107950) | AGIO / FATE / KYTH / SAGE / |
| JONAS JEFFREY M See Remarks | 0.20% (51226) | SAGE / |
| IGUCHI KIMI See Remarks | 0.15% (38345) | SAGE / |
| Kanes Stephen Chief Medical Officer | 0.09% (22948) | SAGE / |
| FRATES JAMES M | 0.02% (5000) | ALKS / SAGE / |
| Anderson Thomas See Remarks | 0.01% (1900) | SAGE / |
UM